Immunogenecity of G250 peptides: rationale for a dendritic cell peptide vaccine trial in patients with advanced renal cell carcinoma

✍ Scribed by Ivar Bleumer; Dorien Tiemessen; Jeanette Oosterwijk-Wakka; Wim Jongmans; Pieter De Mulder; Frans Debruyne; Egbert Oosterwijk; Peter Mulders

• Book ID: 118643929
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 184 KB
• Volume: 1
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/s1569-9056(02)80551-6